Navigation Links
Hybrid antibodies to protect from small pox infection

Researchers Robert H. Purcell, NIAID's Laboratory of Infectious Diseases, and Bernard Moss, NIAID's Laboratory of Viral Diseases have developed a hybrid antibody// which is found to prevent and treat small pox virus infection. Though Small pox virus as been eradicated world wide, there is an increased fear over the use of small pox virus as a bioterrorism tool to kill people.

Small pox referral strains are only available in two places in the world one at CDC, Atlanta and the other at Russian Laboratory. Anti-vaccinia immune globulin (VIG) is the vaccine used worldwide against small pox virus which is prepared from producing antibodies against a weak attenuated smallpox strain in humans and collecting these humanized antibodies from volunteers which can offer immunity against small pox wild strain. The newly prepared vaccine is a hybrid antibody from both chimpanzees and humans immunized antibody, this hybrid antibody as been found to be very effective in controlling the virus in small pox infected mice. The researchers have reported the results of their study in Proceedings of the National Academy of Sciences (PNAS).

Researchers feel that the new hybrid vaccine would be better than the VIG vaccine which causes serious complications in immunocompromised and children’s with skin diseases. The Hybrid vaccine was prepared from combining the antibodies derived from humans and chimpanzees, the bone marrow of hyper-immunized chimpanzees that effectively neutralizes the B5 protein of the virus and also contains the antibodies isolated from small pox humanized individuals containing the two antibodies 8AH7AL and 8AH8AL which effectively neutralized the virus.
'"/>




Page: 1

Related medicine news :

1. NHS To Be Reformed By Using A Hybrid Approach
2. Molecular Imaging Of Cancer Now Possible, New Hybrid Virus Produced
3. Hybrid Nanoparticles for Multimodal Medical Imaging
4. Hybrid Molecule Causes Cancer Cells to Self-Destruct
5. Mutating viruses helps produce antibodies
6. Monoclonal antibodies show promise in treatment of blood cancer
7. Transdermal HRT not cardioprotective in postmenopausal women with CAD
8. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
9. Antioxidants protect health tissue in people undergoing radiation therapy.
10. Morning after pill effective up to five days after having unprotected sex
11. Cats to protect children from asthma
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... , June 23, 2016 ... Oticon , industry leaders in advanced ... launch of Oticon Opn ™, the world,s first ... of possibilities for IoT devices.      (Photo: ... Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology: